Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column.
about
Lysophosphatidic acid in atherosclerotic diseasesInterleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.Roles of lysophosphatidic acid in cardiovascular physiology and diseaseSimple enrichment and analysis of plasma lysophosphatidic acids.Characterization of lysophosphatidic acid subspecies produced by autotaxin using a modified HPLC ESI-MS/MS method.During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.Saliva induces expression of antimicrobial peptides and promotes intracellular killing of bacteria in keratinocytes by epidermal growth factor receptor transactivation.Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.A comprehensive insight into the lipid composition of Myxococcus xanthus by UPLC-ESI-MSChallenges in accurate quantitation of lysophosphatidic acids in human biofluidsQuantitation of phosphatidic acid and lysophosphatidic acid molecular species using hydrophilic interaction liquid chromatography coupled to electrospray ionization high resolution mass spectrometry.Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis.Role of lysophosphatidic acid and its receptors in the kidney.Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress.
P2860
Q34273486-ED8CEB61-6BE6-49C1-A6E1-5580C3FCBCA0Q34944550-E38885CB-9775-4CE9-B55B-72621B7C5771Q35098830-0FADD502-F3CC-4E3A-9732-A520AD346631Q36948520-CF939F30-6293-4EEF-ABC5-0B40A5DC074FQ37593579-19A13076-D733-43B7-9FE0-F208D38BCB82Q37640820-921BDB63-0E16-4C8E-860D-3AC735782034Q39475044-F85B96BF-5641-4143-A5DA-A8AC2E4D27B2Q40601530-70A82985-0348-4652-A128-847518ED7AC9Q41818510-E024CCCD-F205-4B27-A4D5-91AFA350E4F5Q42004226-96E769AF-3714-463F-B9EA-79CF2F339592Q42747131-DCA47C8A-0552-49CA-8829-A04B3E626F49Q43629218-C6F46AB2-3DDC-4E2F-960B-FA47A45AADB1Q47096442-49940F3F-8A0E-4539-9120-A4DC1A22A5C0Q47758727-AE143E12-CD1F-4F35-8247-B28C78F6ABA8Q55007448-39F2A305-B5CA-4018-A895-7CC00512E740
P2860
Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Quantitative determination of ...... a reversed phase HPLC column.
@en
Quantitative determination of ...... a reversed phase HPLC column.
@nl
type
label
Quantitative determination of ...... a reversed phase HPLC column.
@en
Quantitative determination of ...... a reversed phase HPLC column.
@nl
prefLabel
Quantitative determination of ...... a reversed phase HPLC column.
@en
Quantitative determination of ...... a reversed phase HPLC column.
@nl
P2093
P1476
Quantitative determination of ...... a reversed phase HPLC column.
@en
P2093
Keeve Jaffe
Lorelei Davis
Shanping Li
P356
10.1016/J.JCHROMB.2008.01.031
P577
2008-02-02T00:00:00Z